Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ase Industrial Holding Ltd ADR (NY: ASX )

8.585 -0.155 (-1.77%)
Streaming Delayed Price Updated: 10:36 AM EST, Dec 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 694,044
Open 8.710
Bid (Size) 8.580 (138)
Ask (Size) 8.590 (139)
Prev. Close 8.740
Today's Range 8.585 - 8.720
52wk Range 6.160 - 9.030
Shares Outstanding 4,408,018,732
Dividend Yield 6.65%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Brookfield Acknowledges Result of the Origin Energy Shareholder Vote
From Brookfield Renewable Partners L.P.
Via GlobeNewswire

Performance

YTD
+37.14%
+37.14%
1 Month
+6.91%
+6.91%
3 Month
+4.70%
+4.70%
6 Month
+8.12%
+8.12%
1 Year
+27.56%
+27.56%

More News

Read More
Terra Uranium to Present at the OTC Clean Energy and Precious Metals Virtual Investor Conference
From Virtual Investor Conferences
Via GlobeNewswire
ASE Tech Holding Co Earnings Preview
Via Benzinga
Clean Energy and Precious Metals Virtual Investor Conference Agenda Announced for December 4th- December 6th, 2023
From Virtual Investor Conferences
Via GlobeNewswire
Deep Yellow Webcast Live at VirtualInvestorConferences.com
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Commodity Markets: Bitcoin, Bonds, DXY, Gold, Silver, Iron Ore, Copper, Uranium, Oil, Gas, Elliott Wave
Via Talk Markets
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Deutsche Bank ADR Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Appendix 4C – Q1 FY24 Quarterly Cash Flow Report
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Current Analysis: ASE Technology (ASX)
Via Talk Markets
TSMC's Peer ASE Tech Stock Gains In Premarket Here's Why
Via Benzinga
These 15 Undervalued AI Stocks Warrant Your Consideration
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Metals and Mining Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
ASE launches its Integrated Design EcosystemTM to enable silicon package design efficiencies that reduce cycle time by half
From Advanced Semiconductor Engineering, Inc.
Via Business Wire
Fortuna completes acquisition of Chesser Resources, strengthening its presence in West Africa
From Fortuna Silver Mines Inc.
Via GlobeNewswire
5 NYSE-Listed Emerging Market Stocks For Income Investors
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Metals & Mining Virtual Investor Conference Agenda Announced for October 3rd- October 5th
From Virtual Investor Conferences
Via GlobeNewswire
iGaming, Gaming and Entertainment Virtual Investor Conference: Presentations Now Available for Online Viewing
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Hibbett, American Software, Ardelyx And Other Big Stocks Moving Higher On Friday
Via Benzinga
Topics Stocks
Exposures US Equities
Element 25 Limited to Present at the Clean Energy Metals Virtual Investor Conference August 24th
From Virtual Investor Conferences
Via GlobeNewswire
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
From ALTERITY THERAPEUTICS LIMITED
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.